Literature DB >> 3402506

Uptake of 99mTc labelled (Fab')2 fragments of monoclonal antibody 225.28S by a benign ocular naevus.

J Bomanji1, J L Hungerford, M Granowska, K E Britton.   

Abstract

Malignant melanoma is one of the most common primary intraocular neoplasms. Recently, 99mTc radiolabelled (Fab')2 fragments of monoclonal antibody 225.28S raised against cutaneous melanomas have been used for imaging uveal melanomas. We report here a case where uptake of radiolabelled antibody was observed in a choroidal melanoma of the right eye and a benign choroidal naevus of the left.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3402506     DOI： 10.1007/bf00293543

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  9 in total

1.  Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments.

Authors:  J Bomanji; J L Hungerford; M Granowska; K E Britton
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

2.  The use of the 32P test in the management of malignant melanoma of the choroid: a five-year follow-up study.

Authors:  W S Hagler; W H Jarrett; J H Killian
Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol       Date:  1977 Jan-Feb

Review 3.  The 32P test and other methods in the diagnosis of intraocular tumors. (Thesis).

Authors:  R A Van Dijk
Journal:  Doc Ophthalmol       Date:  1978-10-16       Impact factor: 2.379

4.  Benign nevi and malignant melanomas of the choroid.

Authors:  J P Ganley; G W Comstock
Journal:  Am J Ophthalmol       Date:  1973-07       Impact factor: 5.258

5.  Accuracy and limitations of the 32P test in the diagnosis of ocular tumors: an analysis of 500 cases.

Authors:  J A Shields
Journal:  Ophthalmology       Date:  1978-09       Impact factor: 12.079

6.  Characterisation of ocular melanoma with cutaneous melanoma antibodies.

Authors:  J Bomanji; A Garner; J Prasad; D M Albert; J L Hungerford; M Granowska; K E Britton
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

7.  False-positive results with the radioactive phosphorus test.

Authors:  H F Shammas; T C Burton; T A Weingeist
Journal:  Arch Ophthalmol       Date:  1977-12

8.  Current management of choroidal malignant melanoma.

Authors:  J Hungerford
Journal:  Br J Hosp Med       Date:  1985-11

9.  Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.

Authors:  B S Wilson; K Imai; P G Natali; S Ferrone
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396
  9 in total
  4 in total

1.  Ocular melanoma.

Authors:  A B Tullo; C L Dodd; J L Noble; S Owens; H Rao
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

2.  Radioimmunoscintigraphy with melanoma-associated monoclonal antibody fragments in choroidal melanoma.

Authors:  D F Schaling; M J van Kroonenburgh; R A Borsje; J A Camps; H M Kakebeeke-Kemme; J A Oosterhuis; E K Pauwels
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

3.  Immunoimaging of choroidal melanoma: assessment of its diagnostic accuracy and limitations in 101 cases.

Authors:  J Scheidler; G Leinsinger; C M Kirsch; O F Scheiffarth; F H Stefani; K G Riedel
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

4.  Immunoscintigraphy with three step monoclonal pretargeting technique in diagnosis of uveal melanoma: preliminary results.

Authors:  G Modorati; R Brancato; G Paganelli; P Magnani; R Pavoni; F Fazio
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.